Cosmenic.net

Cosmedy Pharmaceutical (operating the domain cosmenic.net) is a Japanese biotechnology company that pioneered the world's first mass-produced dissolving microneedle technology. Founded as a spin-off from Kyoto Pharmaceutical University, the company specializes in transdermal drug delivery systems (TDDS) using biocompatible materials like hyaluronic acid. Their platform allows for the painless administration of vaccines, proteins, and small molecules through the skin's stratum corneum. Beyond its robust cosmetic business under the Quanis brand, Cosmedy is actively developing clinical applications for influenza vaccines and local anesthetics. The company operates GMP-certified manufacturing facilities in Kyoto and collaborates with global pharmaceutical firms to integrate its microneedle technology into next-generation therapeutic delivery.